| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/22/2009 | WO2008135207A8 Implantable system for an intervertebral disc and intervertebral disc implant |
| 01/22/2009 | WO2008134648A3 Cocoa ingredients having enhanced levels of stilbene compounds and methods of producing them |
| 01/22/2009 | WO2008128126A8 Compositions and methods for prophylaxis and treatment of addictions |
| 01/22/2009 | WO2008125600A3 Pyrazole derivatives as p2x7 modulators |
| 01/22/2009 | WO2008122723A3 Use of poly-unsaturated fatty acids and flavonoids as active ingredients in a composition for preventing and/or treating migraines |
| 01/22/2009 | WO2008116813A3 Combination medicaments for treating bacterial infections |
| 01/22/2009 | WO2008116161A3 Pyrazoloanthrone and derivatives thereof for the treatment of cancer expressing 'mullerian inhibiting substance' type ii receptor (misrii) and of excess androgen states |
| 01/22/2009 | WO2008110339A3 Polymorphs of rivastigmine hydrogentartrate |
| 01/22/2009 | WO2008109359A4 Nucleic acid compounds for inhibiting pdgfr family gene expression and uses thereof |
| 01/22/2009 | WO2008109177A3 Metalloprotease inhibitors containing a heterocyclic moiety |
| 01/22/2009 | WO2008083367A4 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 01/22/2009 | WO2008076447A3 Treatments of therapy-resistant diseases comprising drug combinations |
| 01/22/2009 | WO2008073452A8 Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors |
| 01/22/2009 | WO2008070697A4 Stat3 inhibitor having anti-cancer activity and associated methods |
| 01/22/2009 | WO2008063766A3 Amorphous ezetimibe and the production thereof |
| 01/22/2009 | WO2008063202A3 Heterobicyclic thiophene compounds for the treatment of cancer |
| 01/22/2009 | WO2008055013A3 5-oxo-5,8 - dihydro - pyrido - pyrimidines as inhibitors of c-fms kinase |
| 01/22/2009 | WO2008052737A3 Immunochemically equivalent hiv drug analogs |
| 01/22/2009 | WO2008040534A3 Non-mucoadhesive film dosage forms |
| 01/22/2009 | WO2008035371A3 Dietary anti-bacterial compositions |
| 01/22/2009 | WO2008026075A3 Treatment of intracellular bacterial infections with a protein kinase inhibitor or an as160 polypeptide activator |
| 01/22/2009 | WO2007143724A8 Compositions and methods to enhance reverse cholesterol transport |
| 01/22/2009 | WO2007136810A3 Compositions and methods for enhancing mineral levels in animals with reduced environmental impact |
| 01/22/2009 | WO2007136465A3 Compositions and methods for fgf receptor kinases inhibitors |
| 01/22/2009 | WO2007126959A8 Methods and compositions for inducing an immune response to hiv and models for testing |
| 01/22/2009 | WO2007092157A9 7-(1h-imidazol-4-yl) methyl) -5,6,7,8-tetrahydroquinoline |
| 01/22/2009 | WO2006091894A3 New polymeric materials and methods |
| 01/22/2009 | US20090024108 Methods and Devices for Delivery of Compositions to Conduits |
| 01/22/2009 | US20090023920 Imidazole derivatives, their preparation and their use as intermediates for the preparation of pharmaceutical compositions and pesticides |
| 01/22/2009 | US20090023919 Synthesis of temozolomide and analogs |
| 01/22/2009 | US20090023913 Glucopyranosyl-substituted phenyl derivates, medicaments containing such compounds, their use and process for their manufacture |
| 01/22/2009 | US20090023815 Process for the recovery of tyrosol and hydroxytyrosol from oil mill wastewaters and catalytic oxidation method in order to convert tyrosol in hydroxytyrosol |
| 01/22/2009 | US20090023814 Compositions and methods having mt1 receptor activity |
| 01/22/2009 | US20090023813 1 1-(3-Chloro-5-trifluoromethyl-phenyl)-3-(4-chloro-3-trifluoromethyl-phenyl)-urea; sterilization, sanitation, antisepsis, disinfection, decolonisation or prevention of colonisation of the skin, gastro-intestinal tract or the nasal, ocular or dental area or any type of prosthetic device |
| 01/22/2009 | US20090023812 N,n-dihalogenated amino acids and derivatives |
| 01/22/2009 | US20090023811 Biphenyl compound selective agonists of gamma RAR receptors |
| 01/22/2009 | US20090023810 Methods of translation and/or inflammation blockade |
| 01/22/2009 | US20090023808 Production and Purification of Esters of Polyunsaturated Fatty Acids |
| 01/22/2009 | US20090023807 Treatment of Cytokine Dysregulation by Using Sn-2 Gamma-Linolenoyl, Gamma-Diho-Molinolenoyl or Arachidonoyl Patty Acid Glycerol Monoesters |
| 01/22/2009 | US20090023806 Aluminum-storage disease improving agent |
| 01/22/2009 | US20090023805 Method of administration |
| 01/22/2009 | US20090023804 Electrochemical methods for redox control to preserve, stabilize and activate compounds |
| 01/22/2009 | US20090023803 Use of cacao polyphenols for treating a prostate hyperplasia, a specific cacao extract and applications |
| 01/22/2009 | US20090023802 liquid-crystal media used in electro-optical displays; treatment or prophylaxis of diseases or symptoms which can be influenced by inhibition of cannabinoid receptors |
| 01/22/2009 | US20090023801 Inhibitors of beta amyloid production |
| 01/22/2009 | US20090023800 Cannabinoid receptor modulator |
| 01/22/2009 | US20090023799 CRYSTALS OF (2-AMINO-4,5,6,7-TETRAHYDROBENZO[b]THIEN-3-YL)(4-CHLOROPHENYL)METHANONE |
| 01/22/2009 | US20090023798 Thiohydroxamates as inhibitors of histone deacetylase |
| 01/22/2009 | US20090023797 Indol-Alanine Derivatives as Selective S1P4-Agonists |
| 01/22/2009 | US20090023796 Analogs of Indole-3-Carbinol Metabolites as Chemotherapeutic and Chemopreventive Agents |
| 01/22/2009 | US20090023795 Kinase Inhibitors And Methods Of Use Thereof |
| 01/22/2009 | US20090023794 Use of Sumoylation Inhibitors for the Treatment of Neurodegenerative Disease |
| 01/22/2009 | US20090023793 Reducing pigmentation of skin for cosmetic effects by administering tyrosine hydroxylase inhibitors to prevent the biosynthesis of DOPA and catecholamines; thioacetanilide; hyperpigmentation-related medical conditions such as melasma, age spots, freckles, ochronosis, and lentigo |
| 01/22/2009 | US20090023792 reducing pigmentation of skin for cosmetic effects by administering tyrosine hydroxylase inhibitors to prevent the biosynthesis of DOPA and catecholamines; thioacetanilide; hyperpigmentation-related medical conditions such as melasma, age spots, freckles, ochronosis, and lentigo |
| 01/22/2009 | US20090023791 PH-dependent NMDA receptor antagonists |
| 01/22/2009 | US20090023789 N-[(5Z)-4-butyl-2-tert-butylisothiazol-5(2H)-ylidene]-5-chloro-2-methoxybenzamide; CB2 receptors ligand; antiinflammatory, analgesic agent; autoimmune diseases; neuroprotectants |
| 01/22/2009 | US20090023788 Treatment of CRTH2-mediated diseases and conditions |
| 01/22/2009 | US20090023787 Technetium-dipyridine complexes, and methods of use thereof |
| 01/22/2009 | US20090023786 Histone Deacetylase Inhibitor Prodrugs |
| 01/22/2009 | US20090023785 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 01/22/2009 | US20090023784 Use of deferiprone and methods to treat and/or prevent friedreich ataxia resulting from intracellular mishandling of iron |
| 01/22/2009 | US20090023783 (2,4-Dichloro-phenyl)-(3-methyl-6-m-tolyl-benzofuran-2-yl)-methanone; anticarcinogenic, antiproliferative, antitumor agent; solid tumor, metastasis, lymphomas, leukemia; Cell Titre-Glo/High Throughput Assay |
| 01/22/2009 | US20090023781 Haloalkyl Containing Compounds as Cysteine Protease Inhibitors |
| 01/22/2009 | US20090023780 Therapeutic use of a derivative of thienylcyclohexylamine |
| 01/22/2009 | US20090023779 Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents |
| 01/22/2009 | US20090023778 Composition Containing Anti-Dementia Drug |
| 01/22/2009 | US20090023777 Substituted 4-amino-benzylpiperidine compounds |
| 01/22/2009 | US20090023776 Farnesyl protein transferase inhibitor combinations with antiestrogen agents |
| 01/22/2009 | US20090023775 1-[2-(4-benzyl-4-hydroxy-piperidin-1 -yl )-ethyl]-3-(2-methyl-quinolin- 4-yl)- urea as crystalline sulfate salt |
| 01/22/2009 | US20090023774 Pyridine analogs as C5A antagonists |
| 01/22/2009 | US20090023773 Compositions and methods for modulating gated ion channels |
| 01/22/2009 | US20090023772 Novel substituted heteroaryloxy alkylamines and their use as monoamine neurotransmitter re-uptake inhibitors |
| 01/22/2009 | US20090023771 Pharmaceutical composition comprising a proton pump inhibitor and protein component |
| 01/22/2009 | US20090023770 1-methoxy-2-methyl-3-[(4-nitrophenyl)sulphonyl]indolizine, used as angiogenesis inhibitors |
| 01/22/2009 | US20090023769 Organic Compounds |
| 01/22/2009 | US20090023768 Rapamycin derivatives for treating neuroblastoma |
| 01/22/2009 | US20090023767 Anticancer agents; initiasting mitosis which causes tumor cell death |
| 01/22/2009 | US20090023766 Pharmaceutical formulation of apomorphine for buccal administration |
| 01/22/2009 | US20090023765 Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity |
| 01/22/2009 | US20090023764 administering pyrimidinedione compounds such as 1-cyclopropylmethyl-6-(3,5-dimethyl-phenylsulfanyl)-5-isopropyl-1H-pyrimidine-2,4-dione, exhibiting excellent inhibitory activity against hepatitis C virus infections |
| 01/22/2009 | US20090023763 Condensed Pyridine Derivatives Useful as A2B Adenosine Receptor Antagonists |
| 01/22/2009 | US20090023762 Substituted 2-Aminopyrimidine-4-Ones, Their Pharmaceutical Compositions And Their Use In The Treatment And/Or Prevention Of Ab-Related Pathologies |
| 01/22/2009 | US20090023761 Heterocyclic compounds and their uses |
| 01/22/2009 | US20090023760 anticarcinogenic agent; thymidylate synthase (TS) inhibitors; Tri-tert-butyl N-{N-{4-[N-((6RS)-2-methoxymethyl-4-oxo-3,4,7,8-tetrahydro-6H-cyclopenta[g]quinazolin-6-yl)-N-(prop-2-ynyl)amino]benzoyl}-L- gamma -glutamyl}-D-glutamate |
| 01/22/2009 | US20090023759 Quinazoline Derivatives as Inhibitors of EGF and/or erbB2 Receptor Tyrosine Kinase |
| 01/22/2009 | US20090023758 Macrocyclic Inhibitors of Hepatitis C Virus |
| 01/22/2009 | US20090023757 Process for preparing bicyclic compounds |
| 01/22/2009 | US20090023756 Substituted quinazolines as pde10 inhibitors |
| 01/22/2009 | US20090023755 Use of istradefylline for treating behavioral disorders |
| 01/22/2009 | US20090023754 Modified release famciclovir pharmaceutical compositions |
| 01/22/2009 | US20090023753 1,3-Thiazole-5-Carboxamides Useful as Cancer Chemotherapeutic Agents |
| 01/22/2009 | US20090023751 Compounds that protect against sensory hair cell death |
| 01/22/2009 | US20090023750 Novel salts of piperazine compounds as d3/d2 antagonists |
| 01/22/2009 | US20090023749 Crystal structure; antidepressants; anxiolytic agents; eating disorders; bipolar disorders; Alzheimer's disease; sleep disorders; psychiatric disorders; sexual dysfunctions; fibromyalgia |
| 01/22/2009 | US20090023748 Cysteine Protease Inhibitors |
| 01/22/2009 | US20090023747 Cysteine Protease Inhibitors |
| 01/22/2009 | US20090023746 Compounds and their uses 707 |
| 01/22/2009 | US20090023745 Substituted Pyrazolo[4,3-c]Pyridine Derivatives Active as Kinase Inhibitors |
| 01/22/2009 | US20090023744 Combination therapy for depression |
| 01/22/2009 | US20090023743 Inhibitors of protein kinases |